in august, the company successfully completed the world‘sfirsthuman clinicalresearch surgery for the “imie intelligent visual implant” in changsha,china.
prior to february 2019, "glp laboratory" for new generation intelligent retina project of intellimicro medical co., ltd. was completed.
on march 26, 2018, intellimicro medical co., ltd. was officially registered in changsha, china, which is responsible for the development and operation of intelligent retina project.
on december 18, 2017, changsha economic and technological development zone held a signing ceremony for new generation intelligent retina project with golden eye bionics, llc new generation intelligent retina project was formally settled in changsha, china. it will be committed to the industrialization of new generation intelligent retina products, and bringing good news to blind people in china and the world.
in april 2017, the business investigation delegation of people's government of hunan province visited california institute of technology usa, introduced "the project of new generation intelligent retina in usa" to hunan and communicated the project cooperation.
in 2015, pro. mark humayun, the core member of r&d team of new generation intelligent retina won national medal of technology and innovation awarded by the former president obama in person.
in 2005, pro. robert grubbs, the main member of r&d team of new generation intelligent retina won the nobel prize in chemistry.
in 2002, mark humayun invited pro. yu-chong tai, pro. robert grubbs and others to participate in the research and development of new generation intelligent retina and establish a top-class r&d team in the world.
